TLP Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-51,500
Closed -$24K 16
2019
Q1
$24K Sell
51,500
-80,000
-61% -$9.73M 0.33% 12
2018
Q4
$585K Sell
131,500
-9,400
-7% -$1.05M 2.15% 16
2018
Q3
$151K Buy
140,900
+39,400
+39% +$3.94M 0.24% 53
2018
Q2
$262K Buy
101,500
+41,500
+69% +$3.41M 0.4% 44
2018
Q1
$237K Buy
60,000
+26,500
+79% +$2.13M 0.16% 138
2017
Q4
$168K Buy
+33,500
New +$2.85M 0.12% 172

Other funds holding LLY

TLP Group's LLY Position: Q4 2018 in Review

TLP Group sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 14,686 shares — an estimated $1.64M sold.

TLP Group first reported a position in LLY in Q3 2017 and held it in 5 quarters. The position peaked at $2.09M in Q2 2018. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • TLP Group reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 14,686 Eli Lilly shares in Q4 2018, an estimated $1.64M.
  • TLP Group first reported a position in Eli Lilly in Q3 2017 and held it in 5 quarters.
  • TLP Group's Eli Lilly position peaked at $2.09M in Q2 2018.
  • 1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.